Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Freeze Fast
- Development stage
- Unknown
- Lead developer
- Ghimas
- Administration
- Topical
01
Overview
Freeze Fast is a cryotherapeutic cooling spray developed by Ghimas for the immediate treatment of minor physical traumas, such as bruises, strains, sprains, and hematomas. It functions as a consumer health product that provides rapid localized cooling to the skin surface through the evaporation of liquefied propellant gases (typically a mixture of butane, propane, and isobutane). This physical reduction in temperature induces a local anesthetic effect, limits the formation of edema and hematomas, and provides immediate pain relief. It is widely used in sports medicine and first aid for the emergency management of musculoskeletal injuries.
- Brand names
- Freeze Fast
- Other names
- Ghiaccio spray
Beyond the preview
Go deeper on Freeze Fast.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Freeze Fast.